Ranking Member Raskin's Statement on Biden-Harris Administration's Historic Step to Negotiate Medicare Drug Pricing

Press Release

"This historic change fulfills the promise of the Inflation Reduction Act by making critical and life-sustaining medications available to millions of Americans at a lower cost. Since 2019, Oversight Committee Democrats have opposed drug company tactics of keeping drug prices high to gouge the federal government. We have fought to ensure that drugs used to treat cancer, diabetes, and heart disease would be accessible and affordable for Americans managing a health crisis.

Even as our GOP colleagues pursue wild goose chase political vendettas, we are working with the Biden Administration to bring down skyrocketing prescription drug prices. This announcement should provide some peace of mind to seniors and other Americans trying to access the medications they need while still knowing the Inflation Reduction Act will save taxpayers $160 billion in the long run."

Source